Entasis Therapeutics Holdings Inc
(ETTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | |
| Cash Flows From Operating Activities | |
| Net Income | -19,095 |
| Depreciation Amortization | 177 |
| Accounts payable and accrued liabilities | 641 |
| Other Working Capital | 2,395 |
| Other Operating Activity | -71 |
| Operating Cash Flow | $-15,953 |
| Cash Flows From Investing Activities | |
| PPE Investments | -140 |
| Investing Cash Flow | $-140 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 42,192 |
| Financing Cash Flow | $42,192 |
| Beginning Cash Position | 157 |
| End Cash Position | 26,256 |
| Net Cash Flow | $26,099 |
| Free Cash Flow | |
| Operating Cash Flow | -15,953 |
| Capital Expenditure | -140 |
| Free Cash Flow | -16,093 |